Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0364 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1193 | 0.1193 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0364 | 1 | 1 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0364 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.033 | 0.033 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0155 | 0.395 | 0.395 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.064 | 0.064 |
Loa Loa (eye worm) | hypothetical protein | 0.0358 | 0.9822 | 0.9822 |
Mycobacterium ulcerans | hypothetical protein | 0.0215 | 0.5675 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0215 | 0.5675 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1193 | 0.1193 |
Brugia malayi | hypothetical protein | 0.003 | 0.033 | 0.2763 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1193 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.033 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0358 | 0.9822 | 0.9822 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0358 | 0.9822 | 0.9822 |
Loa Loa (eye worm) | hypothetical protein | 0.0364 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0155 | 0.395 | 0.395 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0358 | 0.9822 | 0.9822 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.033 | 0.033 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.0155 | 0.395 | 0.395 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1193 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0358 | 0.9822 | 0.9822 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.064 | 0.064 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0215 | 0.5675 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.033 | 0.033 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0215 | 0.5675 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0364 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.064 | 0.5368 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0364 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.033 | 0.033 |
Giardia lamblia | Hypothetical protein | 0.0215 | 0.5675 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.033 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.033 | 1 |
Onchocerca volvulus | 0.0364 | 1 | 0.5 | |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0209 | 0.5497 | 0.5497 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.033 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.033 | 0.033 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0364 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0155 | 0.395 | 0.395 |
Brugia malayi | hypothetical protein | 0.002 | 0.0017 | 0.0139 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.